Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._

Abstract Background Randomized, placebo-controlled clinical trials (RCTs) that include analytical treatment interruptions (ATI) are conducted to test the efficacy of HIV cure strategies. Two independent RCTs, AELIX-002 and AELIX-003, evaluated the HTI immunogen-based vaccines alone or combined with...

詳細記述

書誌詳細

主要な著者:	Lucia Bailón, Yovaninna Alarcón-Soto, José R. Arribas, Adrian Curran, Anuska Llano, Samandhy Cedeño, Roger Paredes, Elena Vendrame, Devi SenGupta, Jeffrey J. Wallin, Romas Geleziunas, Marie P. Malice, Ian McGowan, Christian Brander, José Moltó, Beatriz Mothe
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Portfolio 2025-12-01
シリーズ:	Communications Medicine
オンライン･アクセス:	https://doi.org/10.1038/s43856-025-01266-y
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!